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pursuant to Section 2 herein during the continuance of this Agreement. You agree that you own no right, 
title or interest in or to the Wiley Materials or any of the intellectual property rights therein. You shall 
have no rights hereunder other than the license as provided for above in Section 2. No right, license or 
 
interest to any trademark, trade name, service mark or other branding ("Marks") of WILEY or its 
licensors is granted hereunder, and you agree that you shall not assert any such right, license or interest 
with respect thereto 
 NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR REPRESENTATION OF 
ANY KIND TO YOU OR ANY THIRD PARTY, EXPRESS, IMPLIED OR STATUTORY, WITH 
RESPECT TO THE MATERIALS OR THE ACCURACY OF ANY INFORMATION CONTAINED IN 
THE MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF 
MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, FITNESS FOR A 
PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-INFRINGEMENT AND ALL 
SUCH WARRANTIES ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND 
WAIVED BY YOU.  
 WILEY shall have the right to terminate this Agreement immediately upon breach of this Agreement by 
you. 
 You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective directors, 
officers, agents and employees, from and against any actual or threatened claims, demands, causes of 
action or proceedings arising from any breach of this Agreement by you. 
 IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY OTHER 
PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, 
INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES, HOWEVER CAUSED, 
ARISING OUT OF OR IN CONNECTION WITH THE DOWNLOADING, PROVISIONING, 
VIEWING OR USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION, WHETHER 
FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE, 
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION, DAMAGES BASED 
ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF THIRD 
PARTIES), AND WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY 
OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE 
OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.  
 Should any provision of this Agreement be held by a court of competent jurisdiction to be illegal, invalid, 
or unenforceable, that provision shall be deemed amended to achieve as nearly as possible the same 
economic effect as the original provision, and the legality, validity and enforceability of the remaining 
provisions of this Agreement shall not be affected or impaired thereby.  
 The failure of either party to enforce any term or condition of this Agreement shall not constitute a 
waiver of either party's right to enforce each and every term and condition of this Agreement. No breach 
under this agreement shall be deemed waived or excused by either party unless such waiver or consent is 
in writing signed by the party granting such waiver or consent. The waiver by or consent of a party to a 
breach of any provision of this Agreement shall not operate or be construed as a waiver of or consent to 
any other or subsequent breach by such other party.  
 This Agreement may not be assigned (including by operation of law or otherwise) by you without 
WILEY's prior written consent. 
 Any fee required for this permission shall be non-refundable after thirty (30) days from receipt by the 
CCC. 
 These terms and conditions together with CCC's Billing and Payment terms and conditions (which are 
incorporated herein) form the entire agreement between you and WILEY concerning this licensing 
transaction and (in the absence of fraud) supersedes all prior agreements and representations of the 
parties, oral or written. This Agreement may not be amended except in writing signed by both parties. 
This Agreement shall be binding upon and inure to the benefit of the parties' successors, legal 
representatives, and authorized assigns.  
 In the event of any conflict between your obligations established by these terms and conditions and those 
established by CCC's Billing and Payment terms and conditions, these terms and conditions shall prevail. 
 WILEY expressly reserves all rights not specifically granted in the combination of (i) the license details 
provided by you and accepted in the course of this licensing transaction, (ii) these terms and conditions 
and (iii) CCC's Billing and Payment terms and conditions. 
 This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was 
misrepresented during the licensing process. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of New 
York, USA, without regards to such state's conflict of law rules. Any legal action, suit or proceeding 
arising out of or relating to these Terms and Conditions or the breach thereof shall be instituted in a court 
of competent jurisdiction in New York County in the State of New York in the United States of America 
and each party hereby consents and submits to the personal jurisdiction of such court, waives any 
objection to venue in such court and consents to service of process by registered or certified mail, return 
receipt requested, at the last known address of such party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS 
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription journals offering Online 
Open. Although most of the fully Open Access journals publish open access articles under the terms of the 
Creative Commons Attribution (CC BY) License only, the subscription journals and a few of the Open Access 
Journals offer a choice of Creative Commons Licenses. The license type is clearly identified on the article. 
The Creative Commons Attribution License 
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and transmit an article, 
adapt the article and make commercial use of the article. The CC-BY license permits commercial and non- 
Creative Commons Attribution Non-Commercial License 
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use, distribution and 
reproduction in any medium, provided the original work is properly cited and is not used for commercial 
purposes.(see below) 
Creative Commons Attribution-Non-Commercial-NoDerivs License 
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) permits use, 
distribution and reproduction in any medium, provided the original work is properly cited, is not used for 
commercial purposes and no modifications or adaptations are made. (see below) 
Use by commercial "for-profit" organizations 
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires further explicit 
permission from Wiley and will be subject to a fee.  
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This Agreement between Reed McDonagh ("You") and John Wiley and Sons ("John Wiley and Sons") consists of 
your license details and the terms and conditions provided by John Wiley and Sons and Copyright Clearance 
Center. 
License Number 3865240581967 
License date May 10, 2016 
Licensed Content Publisher John Wiley and Sons 
Licensed Content Publication Magnetic Resonance in Medicine 
Licensed Content Title Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI 
Licensed Content Author 
Liu Qi Chen,Christine M. Howison,Justin J. Jeffery,Ian F. Robey,Phillip H. 
Kuo,Mark D. Pagel 
Licensed Content Date Nov 26, 2013 
Pages 10 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table 
number(s) 
Figure 4 
Will you be translating? No 
Title of your thesis / 
dissertation 
RADIOPROTECTIVE CERIUM OXIDE NANOPARTICLES: MOLECULAR 
IMAGING INVESTIGATIONS OF CONPS' PHARMACOKINETICS, 
EFFICACY, AND MECHANISMS OF ACTION 
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Sanger Hall 9-005 
 
RICHMOND, VA 23298 
 
United States 
Attn: Reed McDonagh 
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Terms and Conditions  
TERMS AND CONDITIONS  
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or one of its group 
companies (each a"Wiley Company") or handled on behalf of a society with which a Wiley Company has 
exclusive publishing rights in relation to a particular work (collectively "WILEY"). By clicking "accept" in 
connection with completing this licensing transaction, you agree that the following terms and conditions apply to 
this transaction (along with the billing and payment terms and conditions established by the Copyright Clearance 
Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that you opened your RightsLink 
account (these are available at any time at http://myaccount.copyright.com). 
 
Terms and Conditions 
 The materials you have requested permission to reproduce or reuse (the "Wiley Materials") are protected 
by copyright.  
 You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-alone basis), non-
transferable, worldwide, limited license to reproduce the Wiley Materials for the purpose specified in the 
licensing process. This license, and any CONTENT (PDF or image file) purchased as part of your 
order, is for a one-time use only and limited to any maximum distribution number specified in the 
license. The first instance of republication or reuse granted by this license must be completed within two 
years of the date of the grant of this license (although copies prepared before the end date may be 
distributed thereafter). The Wiley Materials shall not be used in any other manner or for any other 
purpose, beyond what is granted in the license. Permission is granted subject to an appropriate 
acknowledgement given to the author, title of the material/book/journal and the publisher. You shall also 
duplicate the copyright notice that appears in the Wiley publication in your use of the Wiley Material. 
Permission is also granted on the understanding that nowhere in the text is a previously published source 
acknowledged for all or part of this Wiley Material. Any third party content is expressly excluded from 
this permission. 
 With respect to the Wiley Materials, all rights are reserved. Except as expressly granted by the terms of 
the license, no part of the Wiley Materials may be copied, modified, adapted (except for minor 
reformatting required by the new Publication), translated, reproduced, transferred or distributed, in any 
form or by any means, and no derivative works may be made based on the Wiley Materials without the 
prior permission of the respective copyright owner.For STM Signatory Publishers clearing permission 
under the terms of the STM Permissions Guidelines only, the terms of the license are extended to 
include subsequent editions and for editions in other languages, provided such editions are for the 
work as a whole in situ and does not involve the separate exploitation of the permitted figures or 
extracts, You may not alter, remove or suppress in any manner any copyright, trademark or other notices 
displayed by the Wiley Materials. You may not license, rent, sell, loan, lease, pledge, offer as security, 
transfer or assign the Wiley Materials on a stand-alone basis, or any of the rights granted to you 
hereunder to any other person. 
 The Wiley Materials and all of the intellectual property rights therein shall at all times remain the 
exclusive property of John Wiley & Sons Inc, the Wiley Companies, or their respective licensors, and 
your interest therein is only that of having possession of and the right to reproduce the Wiley Materials 
pursuant to Section 2 herein during the continuance of this Agreement. You agree that you own no right, 
title or interest in or to the Wiley Materials or any of the intellectual property rights therein. You shall 
have no rights hereunder other than the license as provided for above in Section 2. No right, license or 
 
interest to any trademark, trade name, service mark or other branding ("Marks") of WILEY or its 
licensors is granted hereunder, and you agree that you shall not assert any such right, license or interest 
with respect thereto 
 NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR REPRESENTATION OF 
ANY KIND TO YOU OR ANY THIRD PARTY, EXPRESS, IMPLIED OR STATUTORY, WITH 
RESPECT TO THE MATERIALS OR THE ACCURACY OF ANY INFORMATION CONTAINED IN 
THE MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF 
MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, FITNESS FOR A 
PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-INFRINGEMENT AND ALL 
SUCH WARRANTIES ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND 
WAIVED BY YOU.  
 WILEY shall have the right to terminate this Agreement immediately upon breach of this Agreement by 
you. 
 You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective directors, 
officers, agents and employees, from and against any actual or threatened claims, demands, causes of 
action or proceedings arising from any breach of this Agreement by you. 
 IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY OTHER 
PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, 
INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES, HOWEVER CAUSED, 
ARISING OUT OF OR IN CONNECTION WITH THE DOWNLOADING, PROVISIONING, 
VIEWING OR USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION, WHETHER 
FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE, 
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION, DAMAGES BASED 
ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF THIRD 
PARTIES), AND WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY 
OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE 
OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.  
 Should any provision of this Agreement be held by a court of competent jurisdiction to be illegal, invalid, 
or unenforceable, that provision shall be deemed amended to achieve as nearly as possible the same 
economic effect as the original provision, and the legality, validity and enforceability of the remaining 
provisions of this Agreement shall not be affected or impaired thereby.  
 The failure of either party to enforce any term or condition of this Agreement shall not constitute a 
waiver of either party's right to enforce each and every term and condition of this Agreement. No breach 
under this agreement shall be deemed waived or excused by either party unless such waiver or consent is 
in writing signed by the party granting such waiver or consent. The waiver by or consent of a party to a 
breach of any provision of this Agreement shall not operate or be construed as a waiver of or consent to 
any other or subsequent breach by such other party.  
 This Agreement may not be assigned (including by operation of law or otherwise) by you without 
WILEY's prior written consent. 
 Any fee required for this permission shall be non-refundable after thirty (30) days from receipt by the 
CCC. 
 These terms and conditions together with CCC's Billing and Payment terms and conditions (which are 
incorporated herein) form the entire agreement between you and WILEY concerning this licensing 
transaction and (in the absence of fraud) supersedes all prior agreements and representations of the 
parties, oral or written. This Agreement may not be amended except in writing signed by both parties. 
This Agreement shall be binding upon and inure to the benefit of the parties' successors, legal 
representatives, and authorized assigns.  
 In the event of any conflict between your obligations established by these terms and conditions and those 
established by CCC's Billing and Payment terms and conditions, these terms and conditions shall prevail. 
 WILEY expressly reserves all rights not specifically granted in the combination of (i) the license details 
provided by you and accepted in the course of this licensing transaction, (ii) these terms and conditions 
and (iii) CCC's Billing and Payment terms and conditions. 
 This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was 
misrepresented during the licensing process. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of New 
York, USA, without regards to such state's conflict of law rules. Any legal action, suit or proceeding 
arising out of or relating to these Terms and Conditions or the breach thereof shall be instituted in a court 
of competent jurisdiction in New York County in the State of New York in the United States of America 
and each party hereby consents and submits to the personal jurisdiction of such court, waives any 
objection to venue in such court and consents to service of process by registered or certified mail, return 
receipt requested, at the last known address of such party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS 
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription journals offering Online 
Open. Although most of the fully Open Access journals publish open access articles under the terms of the 
Creative Commons Attribution (CC BY) License only, the subscription journals and a few of the Open Access 
Journals offer a choice of Creative Commons Licenses. The license type is clearly identified on the article. 
The Creative Commons Attribution License 
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and transmit an article, 
adapt the article and make commercial use of the article. The CC-BY license permits commercial and non- 
Creative Commons Attribution Non-Commercial License 
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use, distribution and 
reproduction in any medium, provided the original work is properly cited and is not used for commercial 
purposes.(see below) 
Creative Commons Attribution-Non-Commercial-NoDerivs License 
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) permits use, 
distribution and reproduction in any medium, provided the original work is properly cited, is not used for 
commercial purposes and no modifications or adaptations are made. (see below) 
Use by commercial "for-profit" organizations 
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires further explicit 
permission from Wiley and will be subject to a fee.  
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This Agreement between Reed McDonagh ("You") and John Wiley and Sons ("John Wiley and Sons") consists of 
your license details and the terms and conditions provided by John Wiley and Sons and Copyright Clearance 
Center. 
License Number 3865291296210 
License date May 10, 2016 
Licensed Content 
Publisher 
John Wiley and Sons 
Licensed Content 
Publication 
Magnetic Resonance in Medicine 
Licensed Content Title 
Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for 
pH mapping of kidneys: In vivo studies in mice at 7 T 
Licensed Content Author 
Dario Livio Longo,Walter Dastrù,Giuseppe Digilio,Jochen Keupp,Sander 
Langereis,Stefania Lanzardo,Simone Prestigio,Oliver Steinbach,Enzo Terreno,Fulvio 
Uggeri,Silvio Aime 
Licensed Content Date Oct 14, 2010 
Pages 10 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Electronic 
Portion Figure/table 
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Reed McDonagh 
1101 E Marshall Street 
Sanger Hall 9-005 
 
RICHMOND, VA 23298 
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Attn: Reed McDonagh 
 
Total 0.00 USD  
Terms and Conditions  
TERMS AND CONDITIONS  
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or one of its group 
companies (each a"Wiley Company") or handled on behalf of a society with which a Wiley Company has 
exclusive publishing rights in relation to a particular work (collectively "WILEY"). By clicking "accept" in 
connection with completing this licensing transaction, you agree that the following terms and conditions apply to 
this transaction (along with the billing and payment terms and conditions established by the Copyright Clearance 
Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that you opened your RightsLink 
account (these are available at any time at http://myaccount.copyright.com). 
 
Terms and Conditions 
 The materials you have requested permission to reproduce or reuse (the "Wiley Materials") are protected 
by copyright.  
 You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-alone basis), non-
transferable, worldwide, limited license to reproduce the Wiley Materials for the purpose specified in the 
licensing process. This license, and any CONTENT (PDF or image file) purchased as part of your 
order, is for a one-time use only and limited to any maximum distribution number specified in the 
license. The first instance of republication or reuse granted by this license must be completed within two 
years of the date of the grant of this license (although copies prepared before the end date may be 
distributed thereafter). The Wiley Materials shall not be used in any other manner or for any other 
purpose, beyond what is granted in the license. Permission is granted subject to an appropriate 
acknowledgement given to the author, title of the material/book/journal and the publisher. You shall also 
duplicate the copyright notice that appears in the Wiley publication in your use of the Wiley Material. 
Permission is also granted on the understanding that nowhere in the text is a previously published source 
acknowledged for all or part of this Wiley Material. Any third party content is expressly excluded from 
this permission. 
 With respect to the Wiley Materials, all rights are reserved. Except as expressly granted by the terms of 
the license, no part of the Wiley Materials may be copied, modified, adapted (except for minor 
reformatting required by the new Publication), translated, reproduced, transferred or distributed, in any 
form or by any means, and no derivative works may be made based on the Wiley Materials without the 
prior permission of the respective copyright owner.For STM Signatory Publishers clearing permission 
under the terms of the STM Permissions Guidelines only, the terms of the license are extended to 
include subsequent editions and for editions in other languages, provided such editions are for the 
work as a whole in situ and does not involve the separate exploitation of the permitted figures or 
extracts, You may not alter, remove or suppress in any manner any copyright, trademark or other notices 
displayed by the Wiley Materials. You may not license, rent, sell, loan, lease, pledge, offer as security, 
transfer or assign the Wiley Materials on a stand-alone basis, or any of the rights granted to you 
hereunder to any other person. 
 
 The Wiley Materials and all of the intellectual property rights therein shall at all times remain the 
exclusive property of John Wiley & Sons Inc, the Wiley Companies, or their respective licensors, and 
your interest therein is only that of having possession of and the right to reproduce the Wiley Materials 
pursuant to Section 2 herein during the continuance of this Agreement. You agree that you own no right, 
title or interest in or to the Wiley Materials or any of the intellectual property rights therein. You shall 
have no rights hereunder other than the license as provided for above in Section 2. No right, license or 
interest to any trademark, trade name, service mark or other branding ("Marks") of WILEY or its 
licensors is granted hereunder, and you agree that you shall not assert any such right, license or interest 
with respect thereto 
 NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR REPRESENTATION OF 
ANY KIND TO YOU OR ANY THIRD PARTY, EXPRESS, IMPLIED OR STATUTORY, WITH 
RESPECT TO THE MATERIALS OR THE ACCURACY OF ANY INFORMATION CONTAINED IN 
THE MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF 
MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, FITNESS FOR A 
PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-INFRINGEMENT AND ALL 
SUCH WARRANTIES ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND 
WAIVED BY YOU.  
 WILEY shall have the right to terminate this Agreement immediately upon breach of this Agreement by 
you. 
 You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective directors, 
officers, agents and employees, from and against any actual or threatened claims, demands, causes of 
action or proceedings arising from any breach of this Agreement by you. 
 IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY OTHER 
PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, 
INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES, HOWEVER CAUSED, 
ARISING OUT OF OR IN CONNECTION WITH THE DOWNLOADING, PROVISIONING, 
VIEWING OR USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION, WHETHER 
FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE, 
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION, DAMAGES BASED 
ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF THIRD 
PARTIES), AND WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY 
OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE 
OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.  
 Should any provision of this Agreement be held by a court of competent jurisdiction to be illegal, invalid, 
or unenforceable, that provision shall be deemed amended to achieve as nearly as possible the same 
economic effect as the original provision, and the legality, validity and enforceability of the remaining 
provisions of this Agreement shall not be affected or impaired thereby.  
 The failure of either party to enforce any term or condition of this Agreement shall not constitute a 
waiver of either party's right to enforce each and every term and condition of this Agreement. No breach 
under this agreement shall be deemed waived or excused by either party unless such waiver or consent is 
in writing signed by the party granting such waiver or consent. The waiver by or consent of a party to a 
breach of any provision of this Agreement shall not operate or be construed as a waiver of or consent to 
any other or subsequent breach by such other party.  
 This Agreement may not be assigned (including by operation of law or otherwise) by you without 
WILEY's prior written consent. 
 Any fee required for this permission shall be non-refundable after thirty (30) days from receipt by the 
CCC. 
 These terms and conditions together with CCC's Billing and Payment terms and conditions (which are 
incorporated herein) form the entire agreement between you and WILEY concerning this licensing 
transaction and (in the absence of fraud) supersedes all prior agreements and representations of the 
parties, oral or written. This Agreement may not be amended except in writing signed by both parties. 
This Agreement shall be binding upon and inure to the benefit of the parties' successors, legal 
representatives, and authorized assigns.  
 In the event of any conflict between your obligations established by these terms and conditions and those 
established by CCC's Billing and Payment terms and conditions, these terms and conditions shall prevail. 
 WILEY expressly reserves all rights not specifically granted in the combination of (i) the license details 
provided by you and accepted in the course of this licensing transaction, (ii) these terms and conditions 
and (iii) CCC's Billing and Payment terms and conditions. 
 This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was 
misrepresented during the licensing process. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of New 
York, USA, without regards to such state's conflict of law rules. Any legal action, suit or proceeding 
arising out of or relating to these Terms and Conditions or the breach thereof shall be instituted in a court 
of competent jurisdiction in New York County in the State of New York in the United States of America 
and each party hereby consents and submits to the personal jurisdiction of such court, waives any 
objection to venue in such court and consents to service of process by registered or certified mail, return 
receipt requested, at the last known address of such party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS 
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription journals offering Online 
Open. Although most of the fully Open Access journals publish open access articles under the terms of the 
Creative Commons Attribution (CC BY) License only, the subscription journals and a few of the Open Access 
Journals offer a choice of Creative Commons Licenses. The license type is clearly identified on the article. 
The Creative Commons Attribution License 
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and transmit an article, 
adapt the article and make commercial use of the article. The CC-BY license permits commercial and non- 
Creative Commons Attribution Non-Commercial License 
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use, distribution and 
reproduction in any medium, provided the original work is properly cited and is not used for commercial 
purposes.(see below) 
Creative Commons Attribution-Non-Commercial-NoDerivs License 
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) permits use, 
distribution and reproduction in any medium, provided the original work is properly cited, is not used for 
commercial purposes and no modifications or adaptations are made. (see below) 
Use by commercial "for-profit" organizations 
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires further explicit 
permission from Wiley and will be subject to a fee.  
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